1st tenants for UBuffalo Biosciences Incubator
The University at Buffalo Biosciences Incubator, located at the university's Clinical and Translational Research Center (pictured here), has its first tenants: AccuTheranostics, AndroBioSys and Ceno Technologies. The 4,000 sq.ft. incubator is on the fifth floor of the center which should provide the new clients easy access to equipment and expertise.
Incubator clients pay rent, but receive free access to services such as specialized equipment; seminars on entrepreneurship; guidance on business needs such as marketing; and assistance applying for grants and seeking investment capital.
AccuTheranostics, previously based in the UB Technology Incubator at Baird Research Park in Amherst, is dedicated to helping cancer patients personalize chemotherapy treatment to achieve the best possible results.
AndroBioSys, the brainchild of two Roswell Park Cancer Institute researchers, is developing novel ways to detect, image and treat early prostate cancer.
Ceno Technologies, a materials science company, is moving its biological sciences division to the incubator, where Ceno researchers will study and develop nanoparticles for delivering drugs.
Executives at all three firms cite the UB Biosciences Incubator's proximity to potential research and clinical partners as a key benefit.